Literature DB >> 22092530

Association of vitamin D and antimicrobial peptide production during late-phase allergic responses in the lung.

M C Liu1, H-Q Xiao, A J Brown, C S Ritter, J Schroeder.   

Abstract

BACKGROUND: Vitamin D may play important roles in regulating immune responses and in defence against infectious diseases by effects on both innate and adaptive immune responses. Little is known regarding activation of vitamin D within airway tissues and its relationship to inflammation and antimicrobial responses.
OBJECTIVE: The objective of this study was to investigate the activation of vitamin D within the airways and to define relationships between vitamin D metabolites and measures of inflammatory and antimicrobial responses assessed by bronchoalveolar lavage (BAL) during late-phase responses following allergen challenge of allergic subjects.
METHODS: Segmental allergen challenge was performed with saline and allergen in 16 adult allergic subjects. BAL was performed in both saline and allergen-challenged sites 20-24 h. after challenge. Following extraction from BAL fluids, levels of 25-hydroxy-vitamin D (25(OH)D) and 1,25-dihydroxy-vitamin D (1,25(OH)(2)D) were assayed by specific radioimmunoassays. The cleavage product of cathelicidin, LL-37, was assayed by ELISA. Cellular constituents and albumin were measured.
RESULTS: Levels of vitamin D metabolites were increased in concentrated BAL fluids after allergen compared to saline challenge. Levels of 1,25(OH)(2)D increased from largely undetectable to 2.5 pm (median; range: 1-29.5; P = 0.005) while 25(OH)D increased from 3.2 (0.8-6.2) to 6.2 (1.5-184.9) nm (P = 0.0006). Levels of LL-37 increased from 2.1 (1.4-4.1) to 14.5 (2.2-106.7) ng/mL BAL (P = 0.0005). Levels of LL-37, 1,25(OH)(2)D, and 25(OH)D following allergen challenge were correlated with each other (P < 0.0001), cellular changes, and levels of albumin (P < 0.001). CONCLUSIONS AND CLINICAL RELEVANCE: Levels of vitamin D metabolites, particularly 1,25(OH)(2)D, were low within the airways and increased after allergen challenge. The increases correlated with the magnitude of inflammation and increases in cathelicidin. Normalization to albumin suggested plasma exudation as a mechanism for the increases. The findings support a role for vitamin D in allergic and innate immune responses in the lung.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22092530     DOI: 10.1111/j.1365-2222.2011.03879.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  15 in total

Review 1.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

2.  Lung allograft donors with excessive alcohol use have increased levels of human antimicrobial peptide LL-37.

Authors:  M Camargo Moreno; J B Lewis; E J Kovacs; E M Lowery
Journal:  Alcohol       Date:  2018-11-09       Impact factor: 2.405

3.  Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells.

Authors:  J A Schrumpf; M A J A van Sterkenburg; R M Verhoosel; S Zuyderduyn; P S Hiemstra
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

4.  Vitamin D binding protein and vitamin D in human allergen-induced endobronchial inflammation.

Authors:  K Bratke; A Wendt; K Garbe; M Kuepper; P Julius; M Lommatzsch; J C Virchow
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

Review 5.  Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  Maria Moustaki; Ioanna Loukou; Kostas N Priftis; Konstantinos Douros
Journal:  World J Clin Pediatr       Date:  2017-08-08

6.  Bronchoalveolar Lavage and Plasma Cathelicidin Response to 25-Hydroxy Vitamin D Supplementation: A Pilot Study.

Authors:  Emily C Sanders; Robert M Burkes; Jason R Mock; Todd T Brown; Robert A Wise; Nadia N Hansel; Mark C Liu; M Bradley Drummond
Journal:  Chronic Obstr Pulm Dis       Date:  2021-07-28

7.  A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort.

Authors:  Allison A Lambert; Gregory D Kirk; Jacquie Astemborski; Enid R Neptune; Shruti H Mehta; Robert A Wise; M Bradley Drummond
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

8.  Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 Treatment.

Authors:  Willemien Thijs; Kirsten Janssen; Annemarie M van Schadewijk; Socrates E Papapoulos; Saskia le Cessie; Saskia Middeldorp; Christian F Melissant; Klaus F Rabe; Pieter S Hiemstra
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

9.  Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation.

Authors:  Mahadevappa Hemshekhar; Hadeesha Piyadasa; Dina Mostafa; Leola N Y Chow; Andrew J Halayko; Neeloffer Mookherjee
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

Review 10.  Impact of the Local Inflammatory Environment on Mucosal Vitamin D Metabolism and Signaling in Chronic Inflammatory Lung Diseases.

Authors:  Jasmijn A Schrumpf; Anne M van der Does; Pieter S Hiemstra
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.